AF
RLAY icon

Allworth Financial’s Relay Therapeutics RLAY Stock Holding History

Allworth Financial’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.3K Buy
1,834
+105
+6% +$1.52K ﹤0.01% 2786
2026
Q1 		$17.2K Buy
1,729
+395
+30% +$3.53K ﹤0.01% 3098
2025
Q4 		$11.3K Sell
1,334
-101
-7% -$721 ﹤0.01% 3188
2025
Q3 		$7.49K Buy
1,435
+749
+109% +$2.86K ﹤0.01% 3313
2025
Q2 		$2.37K Buy
686
+4
+0.6% +$12 ﹤0.01% 3626
2025
Q1 		$2.18K Buy
682
+534
+361% +$2.09K ﹤0.01% 3181
2024
Q4 		$729 Sell
148
-170
-53% -$925 ﹤0.01% 3500
2024
Q3 		$2.25K Sell
318
-30
-9% -$224 ﹤0.01% 2920
2024
Q2 		$2.99K Buy
348
+248
+248% +$1.7K ﹤0.01% 2744
2024
Q1 		$830 Hold
100
– – ﹤0.01% 3140
2023
Q4 		$1.1K Hold
100
– – ﹤0.01% 2916
2023
Q3 		$841 Sell
100
-20
-17% -$215 ﹤0.01% 2904
2023
Q2 		$1.51K Buy
120
+20
+20% +$249 ﹤0.01% 2592
2023
Q1 		$1.65K Buy
100
+90
+900% +$1.61K ﹤0.01% 2487
2022
Q4 		$149 Sell
10
-21
-68% -$402 ﹤0.01% 2857
2022
Q3 		$1K Buy
+31
New +$680 ﹤0.01% 2479
2022
Q2 		– Sell
-8
Closed – – 2741
2022
Q1 		$0 Buy
+8
New +$194 ﹤0.01% 2338

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Allworth Financial's RLAY Position: Q2 2026 in Review

Allworth Financial increased its Relay Therapeutics (RLAY) stake by 6.1% in Q2 2026, buying an estimated $1.52K and bringing the position to 1,834 shares worth $34.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2786.

Allworth Financial first reported a position in RLAY in Q1 2022 and has held it in 17 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Allworth Financial held 1,834 shares of Relay Therapeutics worth $34.3K as of Q2 2026.
  • Allworth Financial bought 105 Relay Therapeutics shares in Q2 2026, an estimated $1.52K.
  • Relay Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2786 holding.
  • Allworth Financial first reported a position in Relay Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.